The very-high-efficacy 5-HT 1A receptor agonist, F 13640, preempts the development of allodynia-like behaviors in rats with spinal cord injury

By Wu W.-P.   Hao J.-X.   Xu X.-J.   Wiesenfeld-Hallin Z.   Koek W.   Colpaert F.C.  

European Journal of Pharmacology, Vol. 478, Iss. 2, 2003-10 ,pp. : 131-137

Elsevier

Access to resources Recommend Favorite

Pretreatment with 5-HT 1A receptor agonist flesinoxan attenuates Fos protein in rat hypothalamus

By Compaan J.C.   Groenink L.   Van der Gugten J.   Maes R.A.A.   Olivier B.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 161-168

Elsevier

Access to resources Recommend Favorite

An adenosine kinase inhibitor attenuates tactile allodynia in a rat model of diabetic neuropathic pain

By Lynch J.J.   Jarvis M.F.   Kowaluk E.A.  

European Journal of Pharmacology, Vol. 364, Iss. 2, 1999-01 ,pp. : 141-146

Elsevier

Access to resources Recommend Favorite

Cannabinoid CB 1 receptor upregulation in a rat model of chronic neuropathic pain

By Siegling A.   Hofmann H.A.   Denzer D.   Mauler F.   De Vry J.  

European Journal of Pharmacology, Vol. 415, Iss. 1, 2001-03 ,pp. : 5-7

Elsevier

Access to resources Recommend Favorite

Effect of sustained administration of the 5-HT 1A receptor agonist flesinoxan on rat 5-HT neurotransmission

By Haddjeri N.   Ortemann C.   de Montigny C.   Blier P.  

European Neuropsychopharmacology, Vol. 9, Iss. 5, 1999-09 ,pp. : 427-440

Elsevier

Access to resources Recommend Favorite